Boris Fishman

ABO Blood Group Mismatch in Heart Transplantation Is Not Associated With Elevated Donor-Derived Cell-Free DNA

Donor-derived cell-free DNA (dd-cfDNA) is a reliable, noninvasive marker for detecting allograft rejection after heart transplantation (HT). We evaluated whether dd-cfDNA levels differ in recipients of ABO-compatible, nonidentical (mismatched) grafts. We performed a retrospective...

Glycemic risk stratification in older adults with heart failure: the prognostic role of HbA1c in an aging society

Glycated haemoglobin (HbA1c) is central to diabetes mellitus (DM) management, but its prognostic value in older adults, aged ≥80 years, with heart failure (HF) remains uncertain. Thus, the study aimed to evaluate the association between HbA1c levels and all-cause mortality among...